Concepts (147)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Disaccharides | 8 | 2024 | 12 | 2.580 |
Why?
|
| Galactosylceramides | 8 | 2019 | 12 | 2.430 |
Why?
|
| Furans | 8 | 2023 | 40 | 2.080 |
Why?
|
| Glycosides | 10 | 2017 | 23 | 1.470 |
Why?
|
| Inositol | 3 | 2022 | 20 | 1.370 |
Why?
|
| Acetogenins | 5 | 2023 | 7 | 1.140 |
Why?
|
| Monosaccharides | 3 | 2017 | 13 | 1.010 |
Why?
|
| Arabinose | 2 | 2016 | 3 | 0.990 |
Why?
|
| Xylose | 2 | 2016 | 12 | 0.980 |
Why?
|
| Molecular Structure | 13 | 2024 | 570 | 0.950 |
Why?
|
| Antineoplastic Agents | 5 | 2022 | 1019 | 0.930 |
Why?
|
| Galactosides | 3 | 2015 | 11 | 0.920 |
Why?
|
| Alkenes | 6 | 2022 | 17 | 0.900 |
Why?
|
| Ethers | 4 | 2022 | 21 | 0.890 |
Why?
|
| Adjuvants, Immunologic | 2 | 2017 | 117 | 0.890 |
Why?
|
| Spiro Compounds | 3 | 2009 | 16 | 0.850 |
Why?
|
| Prostatic Neoplasms | 3 | 2023 | 1092 | 0.820 |
Why?
|
| Stereoisomerism | 9 | 2024 | 169 | 0.820 |
Why?
|
| Carbohydrates | 3 | 2023 | 32 | 0.790 |
Why?
|
| Prodrugs | 1 | 2023 | 31 | 0.780 |
Why?
|
| Carbasugars | 1 | 2022 | 1 | 0.750 |
Why?
|
| Fluorine | 2 | 2015 | 17 | 0.720 |
Why?
|
| Cyclization | 7 | 2022 | 50 | 0.660 |
Why?
|
| HIV Envelope Protein gp120 | 3 | 2011 | 54 | 0.590 |
Why?
|
| Tin Compounds | 1 | 2018 | 3 | 0.570 |
Why?
|
| Hydrocarbons, Iodinated | 2 | 2008 | 3 | 0.550 |
Why?
|
| Ceramides | 1 | 2017 | 44 | 0.510 |
Why?
|
| Cholestanol | 1 | 2016 | 2 | 0.500 |
Why?
|
| Lactones | 3 | 2005 | 23 | 0.490 |
Why?
|
| Galactose | 3 | 2024 | 9 | 0.490 |
Why?
|
| Glucosides | 1 | 2016 | 21 | 0.480 |
Why?
|
| Proline | 1 | 2015 | 40 | 0.470 |
Why?
|
| Mannose | 3 | 2022 | 32 | 0.460 |
Why?
|
| Acetamides | 1 | 2015 | 11 | 0.450 |
Why?
|
| Carbon | 1 | 2015 | 128 | 0.430 |
Why?
|
| Glycosphingolipids | 1 | 2014 | 5 | 0.430 |
Why?
|
| Nitrogen | 1 | 2014 | 84 | 0.390 |
Why?
|
| 4-Butyrolactone | 2 | 2023 | 13 | 0.390 |
Why?
|
| Thiophenes | 2 | 2023 | 32 | 0.380 |
Why?
|
| Pyruvate Dehydrogenase (Lipoamide)-Phosphatase | 1 | 2010 | 2 | 0.320 |
Why?
|
| Monensin | 1 | 2009 | 4 | 0.310 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2010 | 49 | 0.310 |
Why?
|
| Antiviral Agents | 1 | 2011 | 195 | 0.300 |
Why?
|
| Carbohydrate Conformation | 5 | 2015 | 15 | 0.300 |
Why?
|
| Cell Line, Tumor | 3 | 2023 | 2676 | 0.290 |
Why?
|
| Structure-Activity Relationship | 5 | 2013 | 506 | 0.280 |
Why?
|
| Cycloparaffins | 1 | 2008 | 2 | 0.280 |
Why?
|
| Anthraquinones | 1 | 2008 | 9 | 0.280 |
Why?
|
| Molecular Conformation | 3 | 2016 | 155 | 0.270 |
Why?
|
| Marine Toxins | 1 | 2007 | 17 | 0.270 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2008 | 139 | 0.260 |
Why?
|
| Models, Molecular | 6 | 2019 | 876 | 0.250 |
Why?
|
| Glycosylphosphatidylinositols | 1 | 2006 | 19 | 0.250 |
Why?
|
| Anti-Bacterial Agents | 1 | 2009 | 432 | 0.240 |
Why?
|
| Pyrans | 1 | 2005 | 10 | 0.230 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2005 | 34 | 0.230 |
Why?
|
| Magnetic Resonance Spectroscopy | 7 | 2009 | 301 | 0.230 |
Why?
|
| Catalysis | 3 | 2015 | 187 | 0.230 |
Why?
|
| Oligosaccharides | 2 | 2007 | 29 | 0.220 |
Why?
|
| Fatty Alcohols | 1 | 2004 | 9 | 0.210 |
Why?
|
| Artemisinins | 1 | 2004 | 19 | 0.210 |
Why?
|
| Amines | 1 | 2004 | 41 | 0.210 |
Why?
|
| Ethers, Cyclic | 1 | 2003 | 5 | 0.210 |
Why?
|
| Antigens, Surface | 1 | 2023 | 52 | 0.190 |
Why?
|
| Trichothecenes | 1 | 2022 | 1 | 0.190 |
Why?
|
| Galactosamine | 1 | 2022 | 4 | 0.190 |
Why?
|
| Swainsonine | 1 | 2001 | 2 | 0.170 |
Why?
|
| Indolizines | 1 | 2001 | 7 | 0.170 |
Why?
|
| Receptors, IgG | 1 | 2000 | 53 | 0.160 |
Why?
|
| Mannosides | 1 | 2019 | 3 | 0.160 |
Why?
|
| Protein Binding | 3 | 2019 | 1082 | 0.160 |
Why?
|
| Concanavalin A | 1 | 2019 | 10 | 0.160 |
Why?
|
| Carbohydrate Sequence | 2 | 2015 | 20 | 0.150 |
Why?
|
| Microarray Analysis | 1 | 2019 | 64 | 0.150 |
Why?
|
| Sphingosine | 1 | 2019 | 22 | 0.150 |
Why?
|
| Oxidation-Reduction | 2 | 2016 | 457 | 0.150 |
Why?
|
| Halogenation | 2 | 2009 | 19 | 0.150 |
Why?
|
| Antigen Presentation | 1 | 2019 | 58 | 0.150 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2000 | 146 | 0.150 |
Why?
|
| Myelin Sheath | 1 | 2019 | 46 | 0.150 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2019 | 55 | 0.140 |
Why?
|
| HIV Infections | 1 | 2011 | 2586 | 0.130 |
Why?
|
| Glycolipids | 2 | 2019 | 10 | 0.130 |
Why?
|
| Humans | 7 | 2023 | 43102 | 0.120 |
Why?
|
| Aldehydes | 1 | 2015 | 70 | 0.110 |
Why?
|
| Male | 3 | 2023 | 23409 | 0.110 |
Why?
|
| Crystallography, X-Ray | 1 | 2015 | 280 | 0.110 |
Why?
|
| Mice | 3 | 2019 | 6644 | 0.110 |
Why?
|
| Macrophages | 1 | 2019 | 529 | 0.110 |
Why?
|
| Hela Cells | 2 | 2013 | 376 | 0.110 |
Why?
|
| Scattering, Radiation | 1 | 2013 | 43 | 0.100 |
Why?
|
| Jurkat Cells | 1 | 2013 | 87 | 0.100 |
Why?
|
| Cytokines | 1 | 2017 | 678 | 0.100 |
Why?
|
| Light | 1 | 2013 | 185 | 0.090 |
Why?
|
| Esters | 1 | 2011 | 25 | 0.090 |
Why?
|
| Micelles | 1 | 2011 | 36 | 0.090 |
Why?
|
| HIV-1 | 2 | 2008 | 755 | 0.080 |
Why?
|
| HIV | 1 | 2011 | 100 | 0.080 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2011 | 127 | 0.080 |
Why?
|
| Receptors, CXCR4 | 1 | 2011 | 74 | 0.080 |
Why?
|
| Surface Properties | 1 | 2011 | 160 | 0.080 |
Why?
|
| Fatty Acids | 1 | 2011 | 134 | 0.080 |
Why?
|
| Cell Survival | 1 | 2013 | 945 | 0.080 |
Why?
|
| Animals | 3 | 2019 | 16992 | 0.070 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 2008 | 8 | 0.070 |
Why?
|
| Enzyme Activation | 1 | 2010 | 462 | 0.070 |
Why?
|
| Virus Internalization | 1 | 2008 | 36 | 0.070 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2008 | 157 | 0.070 |
Why?
|
| Peptides | 1 | 2011 | 372 | 0.070 |
Why?
|
| Cell Line | 1 | 2011 | 1410 | 0.070 |
Why?
|
| Hydrocarbons, Fluorinated | 1 | 2007 | 17 | 0.070 |
Why?
|
| Indicators and Reagents | 1 | 2007 | 61 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 1 | 2008 | 508 | 0.070 |
Why?
|
| P-Selectin | 1 | 2007 | 8 | 0.070 |
Why?
|
| Acids | 1 | 2007 | 19 | 0.060 |
Why?
|
| Cyclohexanes | 1 | 2005 | 30 | 0.060 |
Why?
|
| Sesquiterpenes | 1 | 2005 | 38 | 0.060 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2005 | 140 | 0.050 |
Why?
|
| Anti-HIV Agents | 1 | 2008 | 486 | 0.050 |
Why?
|
| Rats | 1 | 2010 | 3735 | 0.050 |
Why?
|
| Indolizidines | 1 | 2001 | 2 | 0.040 |
Why?
|
| Amination | 1 | 2001 | 6 | 0.040 |
Why?
|
| Glycoside Hydrolases | 1 | 2001 | 7 | 0.040 |
Why?
|
| Alkylation | 1 | 2001 | 11 | 0.040 |
Why?
|
| Spectrophotometry, Infrared | 1 | 2001 | 31 | 0.040 |
Why?
|
| Spectrometry, Mass, Fast Atom Bombardment | 1 | 2000 | 10 | 0.040 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2019 | 25 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2001 | 280 | 0.040 |
Why?
|
| Fluorescence | 1 | 2019 | 118 | 0.040 |
Why?
|
| Interleukin-17 | 1 | 2019 | 53 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2001 | 458 | 0.040 |
Why?
|
| Fluorescent Dyes | 1 | 2019 | 182 | 0.040 |
Why?
|
| Autoantigens | 1 | 2019 | 87 | 0.040 |
Why?
|
| Molecular Sequence Data | 1 | 2000 | 1542 | 0.030 |
Why?
|
| Solanaceous Alkaloids | 1 | 1995 | 1 | 0.030 |
Why?
|
| Phytosterols | 1 | 1995 | 5 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 1869 | 0.030 |
Why?
|
| Membrane Fusion | 1 | 2008 | 11 | 0.020 |
Why?
|
| Molecular Mimicry | 1 | 2007 | 16 | 0.020 |
Why?
|
| Reference Standards | 1 | 2007 | 55 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2007 | 204 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 611 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2007 | 408 | 0.010 |
Why?
|
| Time Factors | 1 | 2007 | 1857 | 0.010 |
Why?
|
| Female | 1 | 2019 | 24698 | 0.010 |
Why?
|
| Chromatography, Thin Layer | 1 | 1995 | 39 | 0.010 |
Why?
|
| Plant Leaves | 1 | 1995 | 136 | 0.010 |
Why?
|